Prosecution Insights
Last updated: May 29, 2026

AltaThera Pharmaceuticals LLC

8 pending office actions • 3 art units • 3 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (62%)
0
Easy (0%)
3
Unknown (38%)

Rejection Statute Mix

BucketCases
§103 only5 (62%)
No statute on record3 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
38% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BARSKY, JARED 4 50.2% +23.0%
MENDEZ, MANUEL A 3 86.1% +8.2%
NGUYEN, JOHN P 1 44.5% +41.6%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18306660 METHODS OF ADMINISTERING DOFETILIDE MENDEZ, MANUEL A 43d
18315790 METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE MENDEZ, MANUEL A 62d
18321220 METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE MENDEZ, MANUEL A 68d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18324703 METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL BARSKY, JARED 131d overdue
18126561 METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE BARSKY, JARED 125d overdue
18417748 METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING BARSKY, JARED 121d overdue
17306490 METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE NGUYEN, JOHN P 30d overdue
17861226 METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING BARSKY, JARED 29d

Top Art Units

Art UnitApps
1628 4
3783 3
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18417748 METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING BARSKY, JARED 1628 Other Non-Final OA 121d overdue Pending Jan 19, 2024
18324703 METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL BARSKY, JARED 1628 Other Non-Final OA 131d overdue Pending May 26, 2023
18321220 METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE MENDEZ, MANUEL A 3783 §103 Non-Final OA 68d Pending May 22, 2023
18315790 METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE MENDEZ, MANUEL A 3783 §103 Non-Final OA 62d Pending May 11, 2023
18306660 METHODS OF ADMINISTERING DOFETILIDE MENDEZ, MANUEL A 3783 §103 Non-Final OA 43d Pending Apr 25, 2023
18126561 METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE BARSKY, JARED 1628 Other Final Rejection 125d overdue Pending Mar 27, 2023
17861226 METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING BARSKY, JARED 1628 §103 Final Rejection 29d Pending Jul 10, 2022
17306490 METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE NGUYEN, JOHN P 1619 §103 Final Rejection 30d overdue Pending May 03, 2021

Managing AltaThera Pharmaceuticals LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month